Abstract
Introduction: Resections for intraductal papillary mucinous neoplasia (IPMN) have increased dramatically. Recurrence pattern and impact of adjuvant chemotherapy for conventional pancreatic adenocarcinoma (PDAC) is well known, but not for invasive IPMN (inv-IPMN). This study aims to elucidate the impact of adjuvant chemotherapy and tempo-spatial recurrence pattern on overall survival (OS) for inv-IPMN compared with PDAC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: HPB : the official journal of the International Hepato Pancreato Biliary Association
Paper Title
Journal
Date
